177 related articles for article (PubMed ID: 33996817)
1. The Transcriptional Co-factor IRF2BP2: A New Player in Tumor Development and Microenvironment.
Pastor TP; Peixoto BC; Viola JPB
Front Cell Dev Biol; 2021; 9():655307. PubMed ID: 33996817
[TBL] [Abstract][Full Text] [Related]
2. IRF2BP2: A new player in the regulation of cell homeostasis.
Ramalho-Oliveira R; Oliveira-Vieira B; Viola JPB
J Leukoc Biol; 2019 Sep; 106(3):717-723. PubMed ID: 31022319
[TBL] [Abstract][Full Text] [Related]
3. The Tumor Suppressor Interferon Regulatory Factor 2 Binding Protein 2 Regulates Hippo Pathway in Liver Cancer by a Feedback Loop in Mice.
Feng X; Lu T; Li J; Yang R; Hu L; Ye Y; Mao F; He L; Xu J; Wang Z; Liu Y; Zhang Y; Ji H; Zhao Y; Cheng S; Tian W; Zhang L
Hepatology; 2020 Jun; 71(6):1988-2004. PubMed ID: 31538665
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of interferon regulatory factor 2 binding protein 2 suppresses gastric cancer progression by negatively regulating connective tissue growth factor.
Yao Y; Wang Y; Li L; Xiang X; Li J; Chen J; Liu Z; Huang S; Xiong J; Deng J
J Cell Mol Med; 2019 Dec; 23(12):8076-8089. PubMed ID: 31559693
[TBL] [Abstract][Full Text] [Related]
5. Control of Pathological Cardiac Hypertrophy by Transcriptional Corepressor IRF2BP2 (Interferon Regulatory Factor-2 Binding Protein 2).
Fang J; Li T; Zhu X; Deng KQ; Ji YX; Fang C; Zhang XJ; Guo JH; Zhang P; Li H; Wei X
Hypertension; 2017 Sep; 70(3):515-523. PubMed ID: 28716987
[TBL] [Abstract][Full Text] [Related]
6. IRF2BP2 transcriptional repressor restrains naive CD4 T cell activation and clonal expansion induced by TCR triggering.
Sécca C; Faget DV; Hanschke SC; Carneiro MS; Bonamino MH; de-Araujo-Souza PS; Viola JP
J Leukoc Biol; 2016 Nov; 100(5):1081-1091. PubMed ID: 27286791
[TBL] [Abstract][Full Text] [Related]
7. IRF2BP2 modulates the crosstalk between glucocorticoid and TNF signaling.
Manjur ABMK; Lempiäinen JK; Malinen M; Palvimo JJ; Niskanen EA
J Steroid Biochem Mol Biol; 2019 Sep; 192():105382. PubMed ID: 31145973
[TBL] [Abstract][Full Text] [Related]
8. IRF2BP2 is a skeletal and cardiac muscle-enriched ischemia-inducible activator of VEGFA expression.
Teng AC; Kuraitis D; Deeke SA; Ahmadi A; Dugan SG; Cheng BL; Crowson MG; Burgon PG; Suuronen EJ; Chen HH; Stewart AF
FASEB J; 2010 Dec; 24(12):4825-34. PubMed ID: 20702774
[TBL] [Abstract][Full Text] [Related]
9. Hepatic IRF2BP2 Mitigates Nonalcoholic Fatty Liver Disease by Directly Repressing the Transcription of ATF3.
Fang J; Ji YX; Zhang P; Cheng L; Chen Y; Chen J; Su Y; Cheng X; Zhang Y; Li T; Zhu X; Zhang XJ; Wei X
Hepatology; 2020 May; 71(5):1592-1608. PubMed ID: 31529495
[TBL] [Abstract][Full Text] [Related]
10. IRF2BP2 Reduces Macrophage Inflammation and Susceptibility to Atherosclerosis.
Chen HH; Keyhanian K; Zhou X; Vilmundarson RO; Almontashiri NA; Cruz SA; Pandey NR; Lerma Yap N; Ho T; Stewart CA; Huang H; Hari A; Geoffrion M; McPherson R; Rayner KJ; Stewart AF
Circ Res; 2015 Sep; 117(8):671-83. PubMed ID: 26195219
[TBL] [Abstract][Full Text] [Related]
11. Savior Siblings Might Rescue Fetal Lethality But Not Adult Lymphoma in Irf2bp2-Null Mice.
Vilmundarson RO; Heydarikhorneh N; Duong A; Ho T; Keyhanian K; Soheili F; Chen HH; Stewart AFR
Front Immunol; 2022; 13():868053. PubMed ID: 35865523
[TBL] [Abstract][Full Text] [Related]
12. Novel frameshift variants expand the map of the genetic defects in IRF2BP2.
García-Aznar JM; Maneiro Pampín E; García Ramos M; Acuña Pérez MJ; Paz Gandiaga N; Minguell Domingo L; Calavia O; Soler-Palacin P; Colobran R; Novoa Bolívar EM; Ocejo Vinyals JG
Front Immunol; 2023; 14():1279171. PubMed ID: 37876937
[TBL] [Abstract][Full Text] [Related]
13. IRF2BP2 prevents ox-LDL-induced inflammation and EMT in endothelial cells via regulation of KLF2.
Jiang Y; Shen Q
Exp Ther Med; 2021 May; 21(5):481. PubMed ID: 33767776
[TBL] [Abstract][Full Text] [Related]
14. Loss of IRF2BP2 in Microglia Increases Inflammation and Functional Deficits after Focal Ischemic Brain Injury.
Cruz SA; Hari A; Qin Z; Couture P; Huang H; Lagace DC; Stewart AFR; Chen HH
Front Cell Neurosci; 2017; 11():201. PubMed ID: 28769762
[TBL] [Abstract][Full Text] [Related]
15. Suppressing Irf2bp2 expressions accelerates metabolic syndrome-associated brain injury and hepatic dyslipidemia.
Ma YL; Xia JL; Gao X
Biochem Biophys Res Commun; 2018 Sep; 503(3):1651-1658. PubMed ID: 30131248
[TBL] [Abstract][Full Text] [Related]
16. IRF2BP2 3'UTR Polymorphism Increases Coronary Artery Calcification in Men.
Vilmundarson RO; Duong A; Soheili F; Chen HH; Stewart AFR
Front Cardiovasc Med; 2021; 8():687645. PubMed ID: 34760935
[TBL] [Abstract][Full Text] [Related]
17. IRF2BP2 counteracts the ATF7/JDP2 AP-1 heterodimer to prevent inflammatory overactivation in acute myeloid leukemia (AML) cells.
Fischer S; Weber LM; Stielow B; Frech M; Simon C; Geller M; Könnecke J; Finkernagel F; Forné I; Nist A; Bauer UM; Stiewe T; Neubauer A; Liefke R
Nucleic Acids Res; 2024 May; ():. PubMed ID: 38801077
[TBL] [Abstract][Full Text] [Related]
18. IRF2BPL Is Associated with Neurological Phenotypes.
Marcogliese PC; Shashi V; Spillmann RC; Stong N; Rosenfeld JA; Koenig MK; Martínez-Agosto JA; Herzog M; Chen AH; Dickson PI; Lin HJ; Vera MU; Salamon N; Graham JM; Ortiz D; Infante E; Steyaert W; Dermaut B; Poppe B; Chung HL; Zuo Z; Lee PT; Kanca O; Xia F; Yang Y; Smith EC; Jasien J; Kansagra S; Spiridigliozzi G; El-Dairi M; Lark R; Riley K; Koeberl DD; Golden-Grant K; ; ; Yamamoto S; Wangler MF; Mirzaa G; Hemelsoet D; Lee B; Nelson SF; Goldstein DB; Bellen HJ; Pena LDM
Am J Hum Genet; 2018 Aug; 103(2):245-260. PubMed ID: 30057031
[TBL] [Abstract][Full Text] [Related]
19. Interferon regulatory factor-2 point mutations in human pancreatic tumors.
Xi H; Blanck G
Int J Cancer; 2000 Sep; 87(6):803-8. PubMed ID: 10956389
[TBL] [Abstract][Full Text] [Related]
20. The NOTCH1-dependent HIF1α/VGLL4/IRF2BP2 oxygen sensing pathway triggers erythropoiesis terminal differentiation.
Wang Y; Liu X; Xie B; Yuan H; Zhang Y; Zhu J
Redox Biol; 2020 Jan; 28():101313. PubMed ID: 31539803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
